The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,614.00
Bid: 2,620.00
Ask: 2,622.00
Change: -22.00 (-0.83%)
Spread: 2.00 (0.076%)
Open: 2,640.00
High: 2,644.00
Low: 2,614.00
Prev. Close: 2,636.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Post 2023 AGM Shareholder Engagement

15 Nov 2023 15:11

RNS Number : 5948T
Coca-Cola HBC AG
15 November 2023
 

 

 

 

Coca-Cola HBC AG

Post 2023 AGM Shareholder Engagement - Update Statement

 

Zug, Switzerland - 15 November 2023 - In accordance with Provision 4 of the UK Corporate Governance Code, Coca-Cola HBC AG ("Coca-Cola HBC" or the "Company") is providing an update to the statement made on 17 May 2023 in relation to the voting outcomes of Resolution 7 and Resolution 9 at its Annual General Meeting ("AGM") which were advisory votes to approve the Company's UK Remuneration Report and Swiss Remuneration Report respectively, as well as Resolution 4.1.3 in relation to the re-election of Charlotte J. Boyle, Chair of the Remuneration Committee (the "Resolutions").

 

The Board of Directors understands the sensitivities around the issue of executive remuneration and it had consulted with its largest shareholders in the months prior to the AGM.

 

At the 2023 AGM, resolutions 7 and 9 to approve our UK Remuneration Report and Swiss Remuneration Report were passed with 68% votes in favour.  Resolution 4.1.3. to approve the re-election of Charlotte J. Boyle as a member of the Board of Directors and as a member of the Remuneration Committee, was passed with 75% votes in favour. Following the AGM, the Company and the Chair of the Remuneration Committee has continued its engagement with shareholders and their proxy advisors on remuneration issues, to understand the reasons why certain shareholders were unable to support these Resolutions.

 

The Company is grateful to those shareholders that took the time to express their views and understands that generally shareholders' primary concerns were connected to the increased 2023 - 2025 PSP opportunity for the CEO, on the basis that, although within the policy limits as approved by shareholders, it was felt that circumstances were not extraordinary and therefore did not justify the increased opportunity. Further context and rationale will be provided in the 2023 Directors' Remuneration Report.

 

The Board recognises the concerns of some of our shareholders and will continue its constructive dialogue with shareholders, considering these views and feedback when setting remuneration going forward.

 

In accordance with the UK Corporate Governance Code, a further update will be provided in the Company's 2023 Integrated Annual Report published in 2024.

 

 

Enquiries

Coca?Cola HBC Group

Investors and Analysts:

John Dawson

Investor Relations Director (Interim)

Tel: +44 7552 619509

john.dawson@cchellenic.com

Jemima Benstead

Investor Relations Manager

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

Marios Matar

Investor Relations Manager

Tel: +30 697 444 3335

marios.matar@cchellenic.com

Virginia Phillips

Investor Relations Manager

Tel: +44 7864 686582

virginia.phillips@cchellenic.com

Media:

Sonia Bastian

Head of Communications

Tel: +41 7946 88054

sonia.bastian@cchellenic.com

 

About Coca?Cola HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We open up moments that refresh us all, by creating value for our stakeholders and supporting the socio-economic development of the communities in which we operate. With a vision to be the leading 24/7 beverage partner, we offer drinks for all occasions around the clock and work together with our customers to serve 740 million consumers across a broad geographic footprint of 29 countries. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, with consumer-leading beverage brands in the sparkling, adult sparkling, juice, water, sport, energy, ready-to-drink tea, coffee, and premium spirits categories. These include Coca-Cola, Coca-Cola Zero Sugar, Fanta, Sprite, Schweppes, Kinley, Costa Coffee, Caffè Vergnano, Valser, FuzeTea, Powerade, Cappy, Monster Energy, The Macallan, Jack Daniel's and Grey Goose. We foster an open and inclusive work environment amongst our 32,000 employees and believe that building a more positive environmental impact is integral to our future growth. We rank among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG, FTSE4Good and ISS ESG.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and is listed on the Athens Exchange (ATHEX: EEE). For more information, please visit https://www.coca-colahellenic.com/

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDNKPBKPBDDADD
Date   Source Headline
3rd May 20245:25 pmRNSTransaction in Own Shares
3rd May 202412:46 pmRNSDirector/PDMR Shareholding
3rd May 202412:38 pmRNSDirector/PDMR Shareholding
2nd May 20245:41 pmRNSTransaction in Own Shares
2nd May 202412:40 pmRNSAthens Exchange trading date of ordinary shares
1st May 20245:47 pmRNSTransaction in Own Shares
1st May 202410:09 amRNSBlock listing Interim Review
1st May 20249:10 amRNSIssue of equity and total voting rights
30th Apr 20247:00 amRNSStrong start; reiterating 2024 guidance
19th Apr 20249:20 amRNSNotice of AGM
18th Apr 20244:21 pmRNSDirector/PDMR Shareholding
5th Apr 20242:17 pmRNSNotice of Results
2nd Apr 202411:12 amRNSIssue of equity and total voting rights
28th Mar 20245:55 pmRNSDirector/PDMR Shareholding
28th Mar 20245:47 pmRNSDirector/PDMR Shareholding
28th Mar 20245:42 pmRNSDirector/PDMR Shareholding
28th Mar 20245:26 pmRNSTransaction in Own Shares
27th Mar 20245:23 pmRNSTransaction in Own Shares
26th Mar 20245:05 pmRNSTransaction in Own Shares
26th Mar 20249:09 amRNSDirector/PDMR Shareholding
25th Mar 20245:10 pmRNSTransaction in Own Shares
22nd Mar 20245:27 pmRNSTransaction in Own Shares - Replacement
22nd Mar 20245:05 pmRNSTransaction in Own Shares
21st Mar 20245:40 pmRNSTransaction in Own Shares
20th Mar 20245:33 pmRNSTransaction in Own Shares
19th Mar 20245:20 pmRNSTransaction in Own Shares
19th Mar 20241:19 pmRNSDirector/PDMR Shareholding
18th Mar 20245:20 pmRNSTransaction in Own Shares
15th Mar 20246:25 pmRNSTransaction in Own Shares
15th Mar 20245:58 pmRNSAnnual Financial Report
14th Mar 20245:30 pmRNSTransaction in Own Shares
14th Mar 20243:04 pmRNSDirector/PDMR Shareholding
14th Mar 20242:56 pmRNSDirector/PDMR Shareholding
13th Mar 20245:20 pmRNSTransaction in Own Shares
12th Mar 20245:15 pmRNSTransaction in Own Shares
11th Mar 20245:50 pmRNSTransaction in Own Shares
8th Mar 20245:45 pmRNSTransaction in Own Shares
7th Mar 20245:20 pmRNSTransaction in Own Shares
6th Mar 20245:10 pmRNSTransaction in Own Shares
5th Mar 20245:15 pmRNSTransaction in Own Shares
4th Mar 20245:55 pmRNSTransaction in Own Shares
1st Mar 20245:15 pmRNSTransaction in Own Shares
1st Mar 20249:25 amRNSIssue of Equity and total voting rights
29th Feb 20245:25 pmRNSTransaction in Own Shares
29th Feb 20243:10 pmRNSDirector/PDMR Shareholding
29th Feb 20243:00 pmRNSDirector/PDMR Shareholding
29th Feb 20242:53 pmRNSDirector/PDMR Shareholding
28th Feb 20245:25 pmRNSTransaction in Own Shares
27th Feb 20245:35 pmRNSTransaction in Own Shares
26th Feb 20245:35 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.